Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.63 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 4/20 | 0.51 |
| ▸ | CA2 | P00918 | 4/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 4/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.43 |
| ▸ | BACE1 | P56817 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20515139 | 0.87 | ALDH1A1 (0.47) | ANPEPERAP2BCHE | |
| SCHEMBL17660268 | 0.85 | ANPEP (0.58) | ANPEPERAP2CA1CA2DNM1 | |
| SCHEMBL29787871 | 0.81 | ANPEP (0.54) | ANPEPERAP2CA1CA2DNM1 | |
| SCHEMBL20902781 | 0.80 | CA1 (0.65) | ANPEPERAP2CA1CA2TP53 | |
| SCHEMBL11221332 | 0.79 | CHRM2 (0.50) | ANPEPERAP2CA1CA2DNM1 | |
| SCHEMBL28854203 | 0.78 | TAAR1 (0.57) | ANPEPERAP2CA1CA2 | |
| SCHEMBL29787818 | 0.78 | L3MBTL1 (0.53) | ANPEPERAP2BCHE | |
| SCHEMBL13330952 | 0.78 | LMNA (0.60) | CA1CA2DNM1 | |
| SCHEMBL22280328 | 0.77 | LMNA (0.59) | ANPEPERAP2CA1CA2DNM1 | |
| SCHEMBL3112742 | 0.77 | ANPEP (0.56) | ANPEPBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025575-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2023-01-26 | — | — | US | disclosed |
| EP-4069418-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | BASF SE (DE) | 2022-10-12 | — | — | EP | disclosed |
| CN-114746179-A | Method for producing amines on copper catalysts | 巴斯夫欧洲公司 | 2022-07-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025575-A1 | PROCESS FOR PREPARING AMINES OVER A COPPER CATALYST | AOC2, SOD1, AOC3 | ANPEP 2071/4885ERAP2 4203/4885CA1 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.